Alex Federation’s Post

Recently Dr Erika Spaeth, Director of Clinical & Scientific Affairs, spoke with Will Mountford from Researchpod about how mutations in your DNA combine to produce a measurable impact on breast cancer risk and prognosis. Listen to the podcast to hear more from Dr Spaeth about the research validating geneType's breast cancer risk assessment and how it can benefit healthcare providers wanting to risk stratify their patients. Listen here: https://lnkd.in/gPTHdR8M The podcast is also available on other platforms including Spotify, Apple iTunes and Google Podcasts. #breastcancer #geneType #breastcancerawareness #genomics

Did you know that all of our Expert Interviews are made into podcasts too? Each month, we interview experts from across healthcare to bring you health information you can trust. From arthritis to prostate cancer, the expert interviews are an easy way to learn about chronic conditions and – most importantly – how to manage them. Tune into all of our Expert Interviews as podcasts: https://lnkd.in/ehcUYFpf

This is exactly why the combination of mammogram screening and genetic education & testing offered by The Boob Bus will be so valuable. There are far too many barriers (both real and perceived) to genetic testing for cancer risk. We will help overcome them. 🧬📚🚌 #riskassessment #cancerprevention #mammogramssavelives

On a recent episode of the GW Center for Integrative Medicine podcast, I had the opportunity to discuss the powerful concepts behind our book, Healing and Cancer. In it, we delve into why conventional cancer treatments need to be integrated with whole person care approaches. There's an incredible amount of science supporting this method. For instance, the tumor microenvironment, immune system responses, and even your gut microbiome play integral roles in cancer's behavior. This isn't just about treating a rogue cell; it's about understanding and nurturing the entire environment in which cancer lives. Watch the full discussion and learn how you can apply these principles: https://bit.ly/3RlWNva

It was such a pleasure to speak with Professor Alex Boussioutas, Alex is one of Australia's most prominent and accomplished Gastroenterologists and in this episode we dive right into a conversation about the latest innovations in cancer surveillance and precision medicine. If you have a keen interest in GI cancers, patient experience and genetics, this episode is for you! https://lnkd.in/dDP9mXdE #podcast #rarecancer #cancer #gastriccancer #bowelcancer #patientexperience #genetics #genomics

Our Paper Accepted for Publication in "Current Genomics"! I'm thrilled to share that our latest paper, "Exploring the Role of Non-Synonymous and Deleterious Variants Identified in Colorectal Cancer: A Multi-Dimensional Computational Scrutiny of Exomes," has been accepted for publication in the esteemed journal "Current Genomics"! Key Insights: - Investigating the intricate role of non-synonymous and deleterious variants in colorectal cancer. - A multi-dimensional computational scrutiny of exomes provides a holistic understanding of the genetic landscape. The journey from exploration to acceptance has been incredible, and we can't wait to share our findings with the scientific community. A heartfelt thank you to the dedicated team and collaborators who made this research possible. Connect with Science: Join us on this exciting venture into the genetics of colorectal cancer. Let's push the boundaries of knowledge together! https://lnkd.in/gCXbRnKb Special thanks to RV College Of Engineering for encouraging my team #ColorectalCancer #Genomics #ResearchAccepted #CurrentGenomics #ComputationalBiology #ScientificDiscovery

The podcast I recently posted was a follow-up to my paper that was published in conjunction with the Ipsos Global Oncology Centre of Expertise back in November 2023. This POV, Mastering Complexity, can be found here (along with the podcast): https://lnkd.in/ggvaV_hh 🚀 This paper is the grand finale of an epic eight-year journey, a series that set out to challenge and decode the enigma of cancer. 🌌 We venture into uncharted territories of cancer treatment, wielding revolutionary tools such as third-generation sequencing, labs on a chip, artificial intelligence, and nanorobots. 🔮 We unveil the extraordinary realm of cancer's complexity, like a cosmic explorer discovering galaxies of mind-boggling numbers and intricate genetic pathways. 🐘 Highlighting nature's ingenious survivors like elephants and mole rats, we unravel their secret shields against cancer, a testament to evolution's miraculous solutions. 💫 We dare to dream of a future where cancer is but a memory, a world where we have harnessed our human complexity and emerged victorious. 🔗 If you haven't read the paper already, the Ipsos Oncology CoE invites you on this thrilling journey, to explore the frontiers of cancer research. Join the conversation, share your insights, and let's shape the future of cancer treatment together... #CancerResearch #Genomics #ArtificialIntelligence #MolecularDiagnostics #PrecisionMedicine #GeneticEngineering #Oncology

🎧 The latest episode of my company's podcast, #UnseenUpside, is now available. In it, we detail how precision oncology represents an exciting shift in cancer treatment from a one-size-fits-all approach to tailoring care to each patient's molecular profile. We also discuss how this revolutionary treatment is advancing cancer care at leading hospitals like St. Jude Children's Research Hospital, a Cambridge Associates client, to not only improve health outcomes but also make treatment more equitable. Listen here: https://ow.ly/ome850QNNSu

On a recent episode of the GW Center for Integrative Medicine podcast, I had the opportunity to discuss the powerful concepts behind our book, Healing and Cancer. In it, we delve into why conventional cancer treatments need to be integrated with whole person care approaches. There's an incredible amount of science supporting this method. For instance, the tumor microenvironment, immune system responses, and even your gut microbiome play integral roles in cancer's behavior. This isn't just about treating a rogue cell; it's about understanding and nurturing the entire environment in which cancer lives. Watch the full discussion and learn how you can apply these principles: https://bit.ly/3RlWNva

In the future, more cancer screening could be done through blood tests - so-called liquid biopsies. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery. In this Faces Of Digital Health Podcast episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples. Thank you Dr. Brian Hashemi, Novigenix SA. https://lnkd.in/dNvhV9jG #healthcare #genomics #liquidbiopsy #cancer